We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bacteriophage Lysin Has Antibiologic Warfare Potential

By Biotechdaily staff writers
Posted on 10 May 2006
Researchers have isolated a bacteriolytic enzyme from bacteriophages that specifically lyses anthrax bacteria over a wide pH range. More...
The lysin, which the investigators have called PlyPH, was described in the April 2006 issue of the Journal of Bacteriology.

That PlyPH is active under both acid and basic conditions suggests that it may useful as an antibiologic warfare agent. "PlyPH works in an extremely wide pH range, from as low as four to as high as eight,” said senior author Dr. Vince Fischetti, professor of bacterial pathogenesis and immunology at Rockefeller University (New York, NY, USA). "I do not know of any other lytic enzyme that has such a broad range of activity.”

PlyPH's extreme specificity means that it may be used freely in the environment with no deleterious effects on beneficial microorganisms. "This feature, and the wide pH range offered by PlyPH, is why we think it could be used as an environmental decontaminant, said Dr. Fischetti.”



Related Links:
Rockefeller University

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.